| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The First Department of Surgery, Kagoshima University School of Medicine, 8-35-1 Sakuragaoka, Kagoshima 890, Japan
Reconstituted basement membrane matrix (Matrigel) has been utilized for in vitro assay of tumor cell invasion in recent years. In the conventional chamber for the invasion assay, however, a large number of cells passed easily through the center of the Matrigel-coated filter because the Matrigel layer could not be completely uniform by the meniscus formation. To prevent the meniscus phenomenon of the Matrigel layer, we devised a water-repellent treatment of the inside wall of the assay chamber with paraffin. Consequently, very few erythrocytes passed through the Matrigel-coated filter of this modified chamber with the erythrocyte assay, which was used to demonstrate the evenness and uniformity of the Matrigel layer on the filter. For quantitating a small number of cells which invaded through the Matrigel-coated filter by the invasion assay, a tetrazolium-based colorimetric 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide) assay was used. The invasive abilities of the eight different cells were determined by this invasion-3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay using the modified chamber with a filter coated with 70 µI of the 0.2-mg/ml Matrigel. After 72 h of incubation, the malignant cell lines significantly exceeded the normal cell lines in the percentage of invasion (P < 0.01). Therefore, the modified invasion-3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay provides a simple, easily reproducible in vitro assay for quantitating tumor cell invasion.
1 This study was supported in part by a Grant-in-Aid for Scientific Research and for Cancer Research from the Ministry of Education, Science and Culture of Japan.
2 Present address: Department of Surgery, The Johns Hopkins University School of Medicine, Ross Building Room 754, 720 Rutland Avenue, Baltimore, Maryland 21205. To whom requests for reprints should be addressed, at First Department of Surgery, Kagoshima University School of Medicine, 8-35-1 Sakuragaoka, Kagoshima 890, Japan.
Received 2/ 8/94. Accepted 5/ 4/94.
This article has been cited by other articles:
![]() |
M. Blank, L. Anafi, G. Zandman-Goddard, I. Krause, S. Goldman, E. Shalev, R. Cervera, J. Font, M. Fridkin, H.-J. Thiesen, et al. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model Int. Immunol., July 1, 2007; 19(7): 857 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, K. E. Green, C. Yallampalli, and Y. L. Dong Adrenomedullin Enhances Invasion by Trophoblast Cell Lines Biol Reprod, October 1, 2005; 73(4): 619 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Stronach, G. C. Sellar, C. Blenkiron, G. J. Rabiasz, K. J. Taylor, E. P. Miller, C. E. Massie, A. Al-Nafussi, J. F. Smyth, D. J. Porteous, et al. Identification of Clinically Relevant Genes on Chromosome 11 in a Functional Model of Ovarian Cancer Tumor Suppression Cancer Res., December 15, 2003; 63(24): 8648 - 8655. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cao, K. M. Mak, and C. S. Lieber DLPC decreases TGF-beta 1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells Am J Physiol Gastrointest Liver Physiol, November 1, 2002; 283(5): G1051 - G1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Gho, W.-H. Yoon, and C.-B. Chae Antiplasmin Activity of a Peptide That Binds to the Receptor-binding Site of Angiogenin J. Biol. Chem., March 15, 2002; 277(12): 9690 - 9694. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sellar, L. Li, K. P. Watt, B. D. Nelkin, G. J. Rabiasz, E. A. Stronach, E. P. Miller, D. J. Porteous, J. F. Smyth, and H. Gabra BARX2 Induces Cadherin 6 Expression and Is a Functional Suppressor of Ovarian Cancer Progression Cancer Res., October 1, 2001; 61(19): 6977 - 6981. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Denkert, M. Köbel, S. Berger, A. Siegert, A. Leclere, U. Trefzer, and S. Hauptmann Expression of Cyclooxygenase 2 in Human Malignant Melanoma Cancer Res., January 1, 2001; 61(1): 303 - 308. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |